Drive your research and development with a leading biotechnology company from Europe
We stand for improved vaccination vectors, succesful cell engineering and new gene therapy tools
SIRION’s project oriented focus on optimization of vector technologies makes us the perfect partner to strengthen your R&D of new therapies.
Within the biotechnology sector SIRION cater to a number of research and development projects, most prominently in therapy development, e.g. the rising demand for custom vector solutions in the gene and CAR-T cell therapy fields.
Contact us to discover how SIRION Biotech can excel your R&D.